The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Mechanism of Human Telomerase Inhibition by BIBR1532, a Synthetic, Non-nucleosidic Drug Candidate
Open accessAbstract
Telomerase, a ribonucleoprotein acting as a reverse transcriptase, has been identified as a target for cancer drug discovery. The synthetic, non-nucleosidic compound, BIBR1532, is a potent and selective telomerase inhibitor capable of inducing senescence in human cancer cells (). In the present study, the mode of drug action was characterized. BIBR1532 inhibits the native and recombinant human telomerase, comprising the human telomerase reverse transcriptase and human telomerase RNA components, with similar potency primarily by interfering with the processivity of the enzyme. Enzyme-kinetic experiments show that BIBR1532 is a mixed-type non-competitive inhibitor and suggest a drug binding site distinct from the sites for deoxyribonucleotides and the DNA primer, respectively. Thus, BIBR1532 defines a novel class of telomerase inhibitor with mechanistic similarities to non-nucleosidic inhibitors of HIV1 reverse transcriptase.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091
Extension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975
Enzyme kinetics; behavior and analysis of rapid equilibrium and steady state enzyme systems
(1994) · International Journal of Biochemistry · doi:10.1016/0020-711x(94)90021-3 · Cited by 2,972
A survey of telomerase activity in human cancer
Shay, J. W., & Bacchetti, S. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00062-2 · Cited by 2,794
Creation of human tumour cells with defined genetic elements
Hahn, W. C., Counter, C. M., Lundberg, A. S., Beijersbergen, R. L., Brooks, M. W., & Weinberg, R. A. (1999) · Nature · doi:10.1038/22780 · Cited by 2,345
Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor
Kohlstaedt, L. A., Wang, J., Friedman, J. M., Rice, P. A., & Steitz, T. A. (1992) · Science · doi:10.1126/science.1377403 · Cited by 1,914
Meyerson, M., Counter, C. M., Eaton, E. N., Ellisen, L. W., Steiner, P., Caddle, S. D., Ziaugra, L., Beijersbergen, R. L., Davidoff, M. J., Liu, Q., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80538-3 · Cited by 1,784
A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis
Greider, C. W., & Blackburn, E. H. (1989) · Nature · doi:10.1038/337331a0 · Cited by 1,643
Morin, G. B. (1989) · Cell · doi:10.1016/0092-8674(89)90035-4 · Cited by 1,495
Huang, H., Chopra, R., Verdine, G. L., & Harrison, S. C. (1998) · Science · doi:10.1126/science.282.5394.1669 · Cited by 1,420
Reverse Transcriptase Motifs in the Catalytic Subunit of Telomerase
Lingner, J., Hughes, T. R., Shevchenko, A., Mann, M., Lundblad, V., & Cech, T. R. (1997) · Science · doi:10.1126/science.276.5312.561 · Cited by 1,269
Self-citationA telomerase component is defective in the human disease dyskeratosis congenita
Mitchell, J. R., Wood, E., & Collins, K. (1999) · Nature · doi:10.1038/990141 · Cited by 1,168
Inhibition of telomerase limits the growth of human cancer cells
Hahn, W. C., Stewart, S. A., Brooks, M. W., York, S. G., Eaton, E., Kurachi, A., Beijersbergen, R. L., Knoll, J. H. M., Meyerson, M., & Weinberg, R. A. (1999) · Nature Medicine · doi:10.1038/13495 · Cited by 1,030
Inhibition of Human Telomerase by a G-Quadruplex-Interactive Compound
Sun, D., Thompson, B., Cathers, B. E., Salazar, M., Kerwin, S. M., Trent, J. O., Jenkins, T. C., Neidle, S., & Hurley, L. H. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm970199z · Cited by 794
Weinrich, S. L., Pruzan, R., Ma, L., Ouellette, M., Tesmer, V. M., Holt, S. E., Bodnar, A. G., Lichtsteiner, S., Kim, N. W., Trager, J. B., et al. (1997) · Nature Genetics · doi:10.1038/ng1297-498 · Cited by 766
Telomere shortening and apoptosis in telomerase-inhibited human tumor cells
Zhang, X., Mar, V., Zhou, W., Harrington, L., & Robinson, M. O. (1999) · Genes & Development · doi:10.1101/gad.13.18.2388 · Cited by 698
Functional requirement of p23 and Hsp90 in telomerase complexes
Holt, S. E., Aisner, D. L., Baur, J., Tesmer, V. M., Dy, M., Ouellette, M., Trager, J. B., Morin, G. B., Toft, D. O., Shay, J. W., et al. (1999) · Genes & Development · doi:10.1101/gad.13.7.817 · Cited by 539
Human telomerase contains evolutionarily conserved catalytic and structural subunits
Harrington, L., Zhou, W., McPhail, T., Oulton, R., Yeung, D. S. K., Mar, V., Bass, M. B., & Robinson, M. O. (1997) · Genes & Development · doi:10.1101/gad.11.23.3109 · Cited by 465
Mechanism of inhibition of HIV-1 reverse transcriptase by non-nucleoside inhibitors
Esnouf, R., Ren, J., Ross, C., Jones, Y., Stammers, D., & Stuart, D. (1995) · Nature Structural & Molecular Biology · doi:10.1038/nsb0495-303 · Cited by 442
A highly selective telomerase inhibitor limiting human cancer cell proliferation
Damm, K., Hemmann, U., Garin‐Chesa, P., Hauel, N., Kauffmann, I., Priepke, H., Niestroj, C., Daiber, C., Enenkel, B., Guilliard, B., et al. (2001) · The EMBO Journal · doi:10.1093/emboj/20.24.6958 · Cited by 422
Self-citationG-quadruplex DNA: A target for drug design
Mergny, J.-L., & Hélène, C. (1998) · Nature Medicine · doi:10.1038/3949 · Cited by 384
Inhibition of human telomerase activity by peptide nucleic acids
Norton, J. C., Piatyszek, M. A., Wright, W. E., Shay, J. W., & Corey, D. R. (1996) · Nature Biotechnology · doi:10.1038/nbt0596-615 · Cited by 343
Strahl, C., & Blackburn, E. H. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.1.53 · Cited by 335
Reconstitution of human telomerase activity in vitro
Beattie, T. L., Zhou, W., Robinson, M. O., & Harrington, L. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70067-3 · Cited by 286
Functional Multimerization of the Human Telomerase Reverse Transcriptase
Beattie, T. L., Zhou, W., Robinson, M. O., & Harrington, L. A. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.18.6151-6160.2001 · Cited by 175
White, L. K., Wright, W. E., & Shay, J. W. (2001) · Trends in Biotechnology · doi:10.1016/s0167-7799(00)01541-9 · Cited by 171
Human telomerase contains two cooperating telomerase RNA molecules
Wenz, C. (2001) · The EMBO Journal · doi:10.1093/emboj/20.13.3526 · Cited by 163
Self-citationAnalysis of Telomerase Processivity
Peng, Y., Mian, S. I., & Lue, N. F. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00268-4 · Cited by 151
One-step affinity purification protocol for human telomerase
Schnapp, G., Rodi, H. P., Rettig, W. J., Schnapp, A., & Damm, K. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.13.3311 · Cited by 112
Self-citationA Mutant of Tetrahymena Telomerase Reverse Transcriptase with Increased Processivity
Bryan, T. M., Goodrich, K. J., & Cech, T. R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003246200 · Cited by 100
Ford, L. P., Suh, J. M., Wright, W. E., & Shay, J. W. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.23.9084-9091.2000 · Cited by 96
Gu, Z., Quan, Y., Zhou, L., Arts, E. J., & Wainberg, M. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.52.31046 · Cited by 88
Template definition by Tetrahymena telomerase reverse transcriptase
Miller, M. C., Liu, J. K., & Collins, K. (2000) · The EMBO Journal · doi:10.1093/emboj/19.16.4412 · Cited by 86
Functional Reconstitution of Human Telomerase Expressed inSaccharomyces cerevisiae
Bachand, F., & Autexier, C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.53.38027 · Cited by 69
Human Telomerase Inhibition by 7-Deaza-2‘-deoxypurine Nucleoside Triphosphates
Fletcher, T. M., Salazar, M., & Chen, S.-F. (1996) · Biochemistry · doi:10.1021/bi961228v · Cited by 66
Bosoy, D., & Lue, N. F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m108168200 · Cited by 49
Inhibition of human telomerase by a retrovirus expressing telomeric antisense RNA
Bisoffi, M., Chakerian, A. E., Fore, M. L., Bryant, J. E., Hernandez, J. P., Moyzis, R. K., & Griffith, J. K. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00049-5 · Cited by 45
Interaction of Deoxyguanosine Nucleotide Analogs with Human Telomerase
Tendian, S. W., & Parker, W. B. (2000) · Molecular Pharmacology · doi:10.1124/mol.57.4.695 · Cited by 34
Quan, Y., Liang, C., Inouye, P., & Wainberg, M. A. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.24.5692 · Cited by 19
Cited by
Aging and aging-related diseases: from molecular mechanisms to interventions and treatments
Guo, J., Huang, X., Dou, L., Yan, M., Shen, T., Tang, W., & Li, J. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01251-0 · Cited by 1,718
Cellular Senescence: Aging, Cancer, and Injury
Calcinotto, A., Kohli, J., Zagato, E., Pellegrini, L., Demaria, M., & Alimonti, A. (2019) · Physiological Reviews · doi:10.1152/physrev.00020.2018 · Cited by 1,270
Exploiting senescence for the treatment of cancer
Wang, L., Lankhorst, L., & Bernards, R. (2022) · Nature Reviews Cancer · doi:10.1038/s41568-022-00450-9 · Cited by 867
Telomerase and cancer therapeutics
Harley, C. B. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2275 · Cited by 728
Telomere maintenance as a target for anticancer drug discovery
Neidle, S., & Parkinson, G. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd793 · Cited by 624
Metadata
- Authors
- Pascolo, E., Wenz, C., Lingner, J., Hauel, N., Priepke, H., Kauffmann, I., Garin-Chesa, P., Rettig, W. J., Damm, K., & Schnapp, A.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-05
- Volume
- 277
- Issue
- 18
- Pages
- 15566-15572
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2014482493
- Cited by
- 326
- References
- 40
- FWCI
- 6.25
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.